Yongye Biotechnology International (NASDAQ:YONG.DL)

CAPS Rating: No stars

The company develops, manufactures, and distributes fulvic-acid-based nutrient compounds for plant and animal feed in China.


Player Avatar goldminingXpert (29.58) Submitted: 5/25/2011 1:21:27 PM : Underperform Start Price: $3.97 YONG.DL Score: +6.75

I'm done with discussing this stock. I've called it a dog since the 7s, its in the 3s now, and if you don't think it is going to 0, nothing I say will change your mind.

Report this Post 9 Replies
Member Avatar marketk (69.66) Submitted: 5/31/2011 9:05:35 AM
Recs: 3

Pre-market: 5.64 +1.89 (50.40%)
May 31, 8:54AM EDT
From Google Finance

Big Gain from CEO's Plans to Purchase of up to $3.0 Million.
I'd hate to be a short right now.....
Could go back down depending on how this is executed, but it looks like its going up from here.
The only reason the stock price took a tumble was from the short selling and accusations.
Not going to comment who is right or wrong about the accusations, but if the market is going to look past that, the stock should jump again from here.

Member Avatar mitcjam (83.62) Submitted: 5/31/2011 10:15:22 AM
Recs: 4

Hahahahah - you get what you deserve!!! Making fraudulent claims to benefit you and your friends always comes back to bite you. You obviously have no ethics and are now being punished.

Member Avatar goldminingXpert (29.58) Submitted: 5/31/2011 1:13:06 PM
Recs: 2

These buyouts never actually occur. Just look at the HRBN nonsense.

Member Avatar TDRH (99.49) Submitted: 5/31/2011 1:30:48 PM
Recs: 1

Nice pop today.

Member Avatar mrkhan1024 (76.00) Submitted: 5/31/2011 2:56:39 PM
Recs: 3

It's not a buyout, Ian. Morgan Stanley is taking a $50 million stake in preferred shares.

Member Avatar mitcjam (83.62) Submitted: 5/31/2011 4:52:39 PM
Recs: 5

Morgan Stanley is buying preferred shares much like Warren Buffet did when Goldman Sachs was significantly undervalued. Additionally, Morgan Stanley now has someone on YONG's Board which should reassure everyone that there is not fraud involved in this company. They simply have a solid product that Chinese farmers can't get enough of.

Ian please refute anything I said here, in all honesty, why are you shorting stocks when you are a gold mining expert with a degree from the prestigious Colorado State.

Member Avatar Nightshaded (20.61) Submitted: 6/13/2011 6:12:29 PM
Recs: 1

Not sure why everyone is talking smack to a guy who not only has a current CAPS rating of 99.24, but was actually right all along. If I were you guys, I would dust off the lens through which you see things, and re-examine your beloved falling stock. Good luck to all.

Member Avatar mrkhan1024 (76.00) Submitted: 7/1/2011 3:01:53 PM
Recs: 5


I hope you're not equating CAPS rating with the ability to correctly choose stocks and make money. He pads his CAPS rating by locking in many small gains, thereby increasing the accuracy component of his rating. His score, which represents the value of his picks against the market, fluctuates wildly and at present is barely holding above zero.

That said, this has nothing to do with CAPS or talking smack. This is about a hit piece he wrote containing wild inaccuracies about YONG which were swiftly pointed out by its management and stockholders. Despite the quality of responses, his article promptly dropped the stock price and started a chain of follow-up articles and supposed research reports continuing to bash the stock. Regardless of where this stock is and where it goes, mouthpieces like him should not be able to slander a stock, put shareholders in the house of pain, and force management to waste time addressing it. Period.

Featured Broker Partners